How we diagnose the antiphospholipid syndrome
- 29 January 2009
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 113 (5), 985-994
- https://doi.org/10.1182/blood-2007-12-129627
Abstract
The antiphospholipid syndrome (APS) is an acquired thrombophilia, characterized by the occurrence of venous and arterial events. This article examines the laboratory and key clinical aspects of APS. Particular focus is given to anti–beta 2-glycoprotein I (β2GPI) antibodies in view of their recent inclusion in the APS classification criteria. The clinical utility of using the β2GPI enzyme-linked immunosorbent assay, in conjunction with the established lupus anticoagulant assays and cardiolipin enzyme-linked immunosorbent assay, for diagnosing and risk stratifying patients suspected of having APS is discussed. The relative importance of the various assays in diagnosing obstetric APS (early and late gestation miscarriages) is explored. The implications of recent epidemiologic findings for possibly understanding the underlying pathophysiologic mechanisms of obstetric APS are highlighted. Insights into which patients with obstetric APS may be at most risk of thrombotic complications are presented.This publication has 101 references indexed in Scilit:
- A Review of β2-Glycoprotein-I Antibody Testing Results From a Peer-Driven Multilaboratory Quality Assurance ProgramAmerican Journal of Clinical Pathology, 2007
- Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samplesJournal of Thrombosis and Haemostasis, 2007
- Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human β2‐glycoprotein I: Mutation studies including residues R39 to R43Arthritis & Rheumatism, 2007
- High‐avidity anti‐β2 glycoprotein I antibodies highly correlate with thrombosis in contrast to low‐avidity anti‐β2 glycoprotein I antibodiesJournal of Thrombosis and Haemostasis, 2006
- Lupus Anticoagulants and Their Relationship with the Inhibitors against Coagulation Factor VIII: Considerations on the Differentiation between the 2 Circulating AnticoagulantsClinical Chemistry, 2005
- Avidity of Anti-β2-Glycoprotein I and Thrombosis or Pregnancy Loss in Patients with Antiphospholipid SyndromeAnnals of the New York Academy of Sciences, 2005
- Lupus anticoagulant testing using plasma spiked with monoclonal antibodies: performance in the UK NEQAS proficiency testing programmeJournal of Thrombosis and Haemostasis, 2004
- Lupus anticoagulant testing: improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methodsBritish Journal of Haematology, 2002
- A chimeric antibody with the human ?1 constant region as a putative standard for assays to detect IgG ?2-glycoprotein I-dependent anticardiolipin and anti-?2-glycoprotein I antibodiesArthritis & Rheumatism, 1999
- Do antibodies to β2-glycoprotein 1 contribute to the better characterization of the antiphospholipid syndrome?Lupus, 1999